Hi, what are you looking for?

According to the latest market report published by Future Market Insights titled ‘Keloid Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027),’the global keloid treatment market is estimated to be worth US$ 3,145.8 Mn by 2017 end, and is expected to expand at a CAGR of 3.4% over the forecast period of 2017–2027 to reach a market valuation of US$ 4,414.6 Mn by the end of 2027.

Global Keloid Treatment Market: Dynamics

The global keloid treatment market growth is substantially driven by the rising prevalence of keloid scars as well as the development of multiple keloids. A growing consciousness among patients regarding their appearance is also driving the market of keloid treatment as keloid scars on the exposed body parts leads to ugly appearances. Other factors that are driving the growth in the keloid treatment market include increasing reimbursement for keloid therapies, formalisation of standard treatment guidelines for keloid and increasing use of combination therapies.

Clinics and hospitals are focussing on the adoption of advanced therapy options. CryoShape is used to reduce the impact of keloid scar and recurrence rate. Sensus Healthcare has developed an advanced superficial radiation therapy device to impart better treatment with limited adverse reactions.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1313

Global Keloid Treatment Market: Segmental Forecast

The global keloid treatment market is segmented based on treatment type, end user and region. On the basis of treatment type, the market has been segmented intoocclusive dressing, compression therapy, cryosurgery, excision, radiation therapy, laser therapy, interferon therapy, intralesional corticosteroid injection and others. Other treatment options include dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod.

Intralesional corticosteroid injection treatment segment dominates the global keloid treatment market as this procedure is considered the gold standard and is being used in combination with other therapies. Intralesional corticosteroid injection is expected to be the second most lucrative segment by treatment type, with a market attractiveness index of 2.1 during the forecast period.

Based on end user, the global keloid treatment market is segmented into hospitals, dermatology clinics, ambulatory surgical centres and others. Thehospitals segment is expected to remain dominant, as most of the radiation therapies and excision procedures are performed in hospitals. Hospitals is the largest segment by end user, which is estimated to represent US$ 1,164.7 Mn, or 37.0% share of the total market in 2017 and is projected to reach a market valuation of US$ 1,643.8 Mn, or 37.2% share of the total market by the end of 2027, expanding at a CAGR of 3.5% in terms of value.

Global Keloid Treatment Market: Regional Analysis

On the basis of region, the global keloid treatment market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and the Middle East & Africa.

 Request a [email protected] https://www.futuremarketinsights.com/toc/rep-gb-1313

North America dominated the global keloid treatment market in 2016 and is expected to continue to dominate the global market throughout the forecast period. North America is the largest region in keloid treatment market, which is estimated to represent US$ 1,105.6 Mn, or 35.1% share of the total market in 2017 and is projected to reach a market valuation of US$ 1,549.6 Mn, or 35.1% of the total market by the end of 2027, expanding at CAGR of 3.4% in terms of value. Clinics in North America are opting advanced treatment therapies that can aid in reduced risk of recurrence.

Global Keloid Treatment Market: Vendor Analysis

Leading players in the global keloid treatment market are launching new portable and mobile radiation therapy devices and are offering better treatment options to patients. Companies are targeting dermatology clinics to market their devices, where patients are provided the first line of treatment for keloid. Some of the players operating in the global keloid treatment market who have been profiled in the report include Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Perrigo Company plc, Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation and Avita Medical Limited.

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain:

Veterinary Glucometers Market: The sales of veterinary glucometers are anticipated to grow at a CAGR of 5.1% through 2032. The global veterinary glucometers market size is currently valued at US$ 336.2 Mn in 2022 and is anticipated to cross the revenue value of US$ 579.4 Mn by 2032

Visual Electrophysiology Market: The global visual electrophysiology marketis expected to record a CAGR of 7.2% during the forecast period 2022-2032, up from US$220.3 Mn in 2022 to reach a valuation of US$475.3 Mn by 2032

Portable Anesthesia Systems Market: The global portable anesthesia systems market is expected to accumulate US$ 462.8 Million in value by 2022-end. During the forecast period ranging from 2022 to 2032, a CAGR worth 6% has been projected for the market, with an expected closing value worth US$ 880.8 Million

SPECT Scanning Services Market: The global SPECT scanning services market is worth US$ 1,950.6 Million in 2022. The SPECT scanning services market is expected to expand at an average CAGR of 7.8% and reach US$ 4,434.8 Million by 2032

Pressotherapy Systems Market: The global pressotherapy systems market size was valued at US$ 174.0 Mn in 2021 and is further projected to expand at a CAGR of 4.1% during the forecast period (2022-2032)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 4-years. Contact Us: Future Market Insights, Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A, Jumeirah Lakes Towers, Dubai, United Arab Emirates For Sales Enquiries: [email protected] Website: https://www.futuremarketinsights.com For Read Report: https://www.futuremarketinsights.com/reports LinkedIn| Twitter| Blogs

The post Keloid Treatment Market size is expected to be US$ 17.9 Billion during the forecast period by 2032 appeared first on Future Market Insights.

By using both laboratory-grown brain cells and a 3D brain model, the researchers examined whether VZV infection caused the accumulation of beta amyloid and...

How to upset Russian freight companies, Elon Musk, Chinese authorities and Kylie Jenner in one go? Track their jets. 

The more the sun shines in the German town of Aurach, the more likely it is that Jens Husemann's solar panels will be disconnected.

London's under-fire police force strip-searched more than 600 children over a two-year period.

COPYRIGHT © 1998 - 2022 DIGITAL JOURNAL INC. Digital Journal is not responsible for the content of external sites. Read more about our external linking.